Bayer/Monsanto Hit Again With $2 Billion Verdict in Roundup Case
This blog has closely followed litigation surrounding allegations that glyphosate has caused non-Hodgkin lymphoma in a number of plaintiffs. In March, a California jury awarded $80 million in damages to a plaintiff who used Monsanto’s Roundup on his 56-acre property. This verdict was the second significant glyphosate judgment against Bayer-owned Monsanto, following on the August 2018 verdict that awarded a former school groundskeeper $289 million (later reduced to $78 million by a judge reviewing the case).
Most recently, on May 12, in Pilliod v. Monsanto, a California jury concluded that Monsanto’s Roundup caused a couple to suffer non-Hodgkin lymphoma after years of using the herbicide and awarded the plaintiffs a total of $2 billion in punitive damages and $55 million in compensatory damages.
This is the third consecutive loss for Bayer AG, which acquired Monsanto in June 2018, and the third to go to trial out of about 13,400 cases pending that allege Roundup causes cancer. Bayer said in a statement that the company is disappointed with the jury’s decision and will appeal the verdict.